NEXITYSociété anonymeau capital de 280 648 620 eurosSiège Social : 67 rue Arago 93400 Saint-Ouen-sur-Seine444 346 795 RCS Bobigny Monthly disclosure of the total numberof voting rights and shares composing the share capital in accordance with Articles L. 233-8-II of the French Commercial Code and 223-16 of the General Regulation of the Autorité des Marchés FinanciersInformation cut-off date Total numberof shares Net total number ofvoting rights29 May 2026   56,129,724   Total gross 56,129,724Net total 55,687,282* Net total = Total number of voting rights attached to the shares – shares without voting rights Saint-Ouen-sur-Seine, 2 June 2026Attachment2026_06_02 – Monthly disclosure of voting rights and shares – May 2026

Financial Press ReleaseMaison Pommery & Associés enters into exclusive negotiations with Henkell International for a strategic partnership Reims, 2 June 2026 Maison Pommery & Associés (Euronext Paris, ISIN FR0000062796, Euronext Brussels, ISIN NSCBE0002798) announces that it is entering into exclusive negotiations with Henkell International for a two-month period regarding a proposed strategic combination that would include Henkell International becoming a majority shareholder in Maison Pommery & Associés. This proposed partnership between two family-owned groups would create a global player in sparkling wine, benefiting from a portfolio of strong and complementary brands, as well as an international commercial presence. At this stage, the discussions remain subject to due diligence work, the parties’ agreement on the execution...

$8.5 million upfront with up to approximately $15.1 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash, it is anticipated that the cash runway would extend well beyond FDA approval and first full year of commercialization ACTON, Mass., June 02, 2026 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on near-patient testing for critical care, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 3,655,917 shares of common stock (or pre-funded warrant in lieu thereof), series G warrants to purchase up to 3,655,917 shares...

Dear Shareholders, We are pleased to send you, in the attached document, GENFIT’s Shareholders’ Letter published ahead of our Annual General Meeting to be held on June 15, 2026. This letter outlines the key elements currently shaping the Company’s trajectory and presents the main milestones and perspectives related to its activities. We remind you that you are invited to attend this General Meeting, which will take place on June 15, 2026 in Lille, and during which you will be able to cast your vote on the proposed resolutions. Important: If you would like to stay informed about our latest news, please remember to subscribe to our newsletter via the following link: I would like to stay informed about GENFIT latest news Thank you for your attention and your continued support.The Executive Management of GENFITAttachmentGENFIT...

02 June 2026 Disclosure of trading in own shares under a share buyback program Period: From 25 to 29 May 2026 Issuer’s registered name: Ipsos Issuer’s Identification code: 9695002OY2X35E9X8W87 Financial instrument reference: Ordinary shares – ISIN code FR0000073298 Reporting of transactions in aggregated form (per day and per trading venue)Issuer name Issuer Code Transaction date ISIN Code Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform      ISIN code (ISO 6166)     MIC code (ISO 10383)IPSOS 9695002OY2X35E9X8W87 25-May-26 FR0000073298 9 570 37,2555 XPARIPSOS 9695002OY2X35E9X8W87 25-May-26 FR0000073298 3 850 37,2489 DXEIPSOS 9695002OY2X35E9X8W87 26-May-26 FR0000073298 10 474 37,2700 XPARIPSOS 9695002OY2X35E9X8W87 26-May-26 FR0000073298 2 942 37,2554 DXEIPSOS 9695002OY2X35E9X8W87 27-May-26 FR0000073298 9...

PRESS RELEASE STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE Paris, June 2nd , 2026, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) announces that its stock continues to be covered by Stonegate Capital Partners, a leading independent US-based research and investor outreach firm, which has updated its coverage of the stock following the publication of AB Science’s full year 2025 results, supported by a discounted cash flow valuation with a mid-point of €4.25 per share (range of €3.20 to €5.77 per share). Stonegate Capital Partners issued this update in a research note entitled “Stonegate Capital Partners Updates Coverage on AB Science S.A. (ENXTPA: AB) 1Q26”, published on 26 May 2026. In this update, Stonegate maintained its coverage...

Amundi Annual General MeetingAll resolutions approved with an average approval rate of 98,29% Amundi’s Annual General Meeting was held on Tuesday 2 June 2026. With a quorum of 93,47 %, the Meeting approved all the resolutions submitted by the Board of Directors, with an average approval rate of 98,29%. After approving the financial statements for 2025, the General Meeting of Amundi approved the distribution of a dividend of €4.25 per share. The ex-dividend date is set at 9 June 2026 and the dividend will be paid from 11 June 2026. The detailed results of the votes of the General Meeting will be available on the website https://about.amundi.com/ within the regulatory timeframe. About AmundiAmundi, the leading European asset manager, ranking among the top 10 global players1, offers over 200 million investors a complete range of savings and...

PRESS RELEASEJune 2, 2026NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED) OR IN OR INTO CANADA, JAPAN, SOUTH AFRICA, AUSTRALIA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS PRESS RELEASE RENAULT GROUP SUCCESSFULLY ISSUES A €750 MILLION BOND Boulogne-Billancourt, June 2, 2026 – Renault Group announces the successful placement of a 750 million euros bond issue maturing June 9, 2031, and carrying a coupon of 4.125%. This issue was largely oversubscribed, underlying strong credit investor confidence in Renault Group’s robust financial position, as evidenced by its improved credit rating, and in its new strategic plan, futuREady. This issuance allows Renault Group to benefit from...

TORONTO, June 02, 2026 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to provide a summary of past and follow-up exploration efforts by Globex at its Salt Spring Gold Project. The properties main claim block was staked in September 2023 and was expanded by staking in March 2025 and again in March 2026. It is in northwestern Arizona, Mohave County, 85 km southeast of the city of Las Vegas, Nevada. The Salt Spring property now consists now of 57 unpatented lode claims. The property has a total surface area of 471.77 ha. Highlights of recent Exploration:Exploration efforts including soil sampling,...